Revolutionizing Medical Research

---

We intend to apply for a NIH grant or from the DOW to extend this work.

The safety of the our product has been evaluated under cGLP condition with support from NIH grant:

2R44Al142964-02, which demonstrated that a dose 20x that of the effective dose is still safe

with no harm to all the organ/tissues studied.